Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

Advancing vaccine development for gonorrhoea and the Global STI Vaccine Roadmap.

Gottlieb SL, Jerse AE, Delany-Moretlwe S, Deal C, Giersing BK.

Sex Health. 2019 Sep 3. doi: 10.1071/SH19060. [Epub ahead of print]

PMID:
31476278
2.

Advancing the public health applications of Chlamydia trachomatis serology.

Woodhall SC, Gorwitz RJ, Migchelsen SJ, Gottlieb SL, Horner PJ, Geisler WM, Winstanley C, Hufnagel K, Waterboer T, Martin DL, Huston WM, Gaydos CA, Deal C, Unemo M, Dunbar JK, Bernstein K.

Lancet Infect Dis. 2018 Dec;18(12):e399-e407. doi: 10.1016/S1473-3099(18)30159-2. Epub 2018 Jul 5. Review.

PMID:
29983342
3.

Correction: Prevalence of sexually transmitted infections and bacterial vaginosis among women in sub-Saharan Africa: An individual participant data meta-analysis of 18 HIV prevention studies.

Torrone EA, Morrison CS, Chen PL, Kwok C, Francis SC, Hayes RJ, Looker KJ, McCormack S, McGrath N, van de Wijgert JHHM, Watson-Jones D, Low N, Gottlieb SL; STIMA Working Group.

PLoS Med. 2018 Jun 26;15(6):e1002608. doi: 10.1371/journal.pmed.1002608. eCollection 2018 Jun.

4.

Review of mathematical models of HSV-2 vaccination: Implications for vaccine development.

Spicknall IH, Looker KJ, Gottlieb SL, Chesson HW, Schiffer JT, Elmes J, Boily MC.

Vaccine. 2018 Apr 3. pii: S0264-410X(18)30254-8. doi: 10.1016/j.vaccine.2018.02.067. [Epub ahead of print]

5.

Prevalence of sexually transmitted infections and bacterial vaginosis among women in sub-Saharan Africa: An individual participant data meta-analysis of 18 HIV prevention studies.

Torrone EA, Morrison CS, Chen PL, Kwok C, Francis SC, Hayes RJ, Looker KJ, McCormack S, McGrath N, van de Wijgert JHHM, Watson-Jones D, Low N, Gottlieb SL; STIMA Working Group.

PLoS Med. 2018 Feb 27;15(2):e1002511. doi: 10.1371/journal.pmed.1002511. eCollection 2018 Feb. Erratum in: PLoS Med. 2018 Jun 26;15(6):e1002608.

6.

Meeting report: Initial World Health Organization consultation on herpes simplex virus (HSV) vaccine preferred product characteristics, March 2017.

Gottlieb SL, Giersing BK, Hickling J, Jones R, Deal C, Kaslow DC; HSV Vaccine Expert Consultation Group.

Vaccine. 2017 Dec 7. pii: S0264-410X(17)31492-5. doi: 10.1016/j.vaccine.2017.10.084. [Epub ahead of print]

PMID:
29224963
7.

Biologic interactions between HSV-2 and HIV-1 and possible implications for HSV vaccine development.

Schiffer JT, Gottlieb SL.

Vaccine. 2017 Sep 25. pii: S0264-410X(17)31273-2. doi: 10.1016/j.vaccine.2017.09.044. [Epub ahead of print]

8.

Effect of HSV-2 infection on subsequent HIV acquisition: an updated systematic review and meta-analysis.

Looker KJ, Elmes JAR, Gottlieb SL, Schiffer JT, Vickerman P, Turner KME, Boily MC.

Lancet Infect Dis. 2017 Dec;17(12):1303-1316. doi: 10.1016/S1473-3099(17)30405-X. Epub 2017 Aug 23. Review.

9.

Modelling efforts needed to advance herpes simplex virus (HSV) vaccine development: Key findings from the World Health Organization Consultation on HSV Vaccine Impact Modelling.

Gottlieb SL, Giersing B, Boily MC, Chesson H, Looker KJ, Schiffer J, Spicknall I, Hutubessy R, Broutet N; WHO HSV Vaccine Impact Modelling Meeting Working Group.

Vaccine. 2017 Jun 21. pii: S0264-410X(17)30408-5. doi: 10.1016/j.vaccine.2017.03.074. [Epub ahead of print]

10.

First estimates of the global and regional incidence of neonatal herpes infection.

Looker KJ, Magaret AS, May MT, Turner KME, Vickerman P, Newman LM, Gottlieb SL.

Lancet Glob Health. 2017 Mar;5(3):e300-e309. doi: 10.1016/S2214-109X(16)30362-X. Epub 2017 Jan 31.

11.

Status of vaccine research and development of vaccines for Chlamydia trachomatis infection.

Poston TB, Gottlieb SL, Darville T.

Vaccine. 2017 Jan 19. pii: S0264-410X(17)30042-7. doi: 10.1016/j.vaccine.2017.01.023. [Epub ahead of print]

PMID:
28111145
12.

Future prospects for new vaccines against sexually transmitted infections.

Gottlieb SL, Johnston C.

Curr Opin Infect Dis. 2017 Feb;30(1):77-86. doi: 10.1097/QCO.0000000000000343. Review.

13.

The global roadmap for advancing development of vaccines against sexually transmitted infections: Update and next steps.

Gottlieb SL, Deal CD, Giersing B, Rees H, Bolan G, Johnston C, Timms P, Gray-Owen SD, Jerse AE, Cameron CE, Moorthy VS, Kiarie J, Broutet N.

Vaccine. 2016 Jun 3;34(26):2939-2947. doi: 10.1016/j.vaccine.2016.03.111. Epub 2016 Apr 19. Review.

14.

Status of vaccine research and development of vaccines for herpes simplex virus.

Johnston C, Gottlieb SL, Wald A.

Vaccine. 2016 Jun 3;34(26):2948-2952. doi: 10.1016/j.vaccine.2015.12.076. Epub 2016 Mar 11. Review.

15.

Global and Regional Estimates of Prevalent and Incident Herpes Simplex Virus Type 1 Infections in 2012.

Looker KJ, Magaret AS, May MT, Turner KM, Vickerman P, Gottlieb SL, Newman LM.

PLoS One. 2015 Oct 28;10(10):e0140765. doi: 10.1371/journal.pone.0140765. eCollection 2015.

16.

Correction: Global estimates of prevalent and incident herpes simplex virus type 2 infections in 2012.

Looker KJ, Magaret AS, Turner KM, Vickerman P, Gottlieb SL, Newman LM.

PLoS One. 2015 May 20;10(5):e0128615. doi: 10.1371/journal.pone.0128615. eCollection 2015. No abstract available.

17.

Pelvic inflammatory disease.

Brunham RC, Gottlieb SL, Paavonen J.

N Engl J Med. 2015 May 21;372(21):2039-48. doi: 10.1056/NEJMra1411426. Review. No abstract available.

PMID:
25992748
18.

Global estimates of prevalent and incident herpes simplex virus type 2 infections in 2012.

Looker KJ, Magaret AS, Turner KM, Vickerman P, Gottlieb SL, Newman LM.

PLoS One. 2015 Jan 21;10(1):e114989. doi: 10.1371/journal.pone.0114989. eCollection 2015. Erratum in: PLoS One. 2015;10(5):e0128615.

19.

Trends and patterns of sexual behaviors among adolescents and adults aged 14 to 59 years, United States.

Liu G, Hariri S, Bradley H, Gottlieb SL, Leichliter JS, Markowitz LE.

Sex Transm Dis. 2015 Jan;42(1):20-6. doi: 10.1097/OLQ.0000000000000231.

20.

Toward global prevention of sexually transmitted infections (STIs): the need for STI vaccines.

Gottlieb SL, Low N, Newman LM, Bolan G, Kamb M, Broutet N.

Vaccine. 2014 Mar 20;32(14):1527-35. doi: 10.1016/j.vaccine.2013.07.087. Epub 2014 Feb 25.

21.

Vaccines against sexually transmitted infections: the way forward.

Broutet N, Fruth U, Deal C, Gottlieb SL, Rees H; participants of the 2013 STI Vaccine Technical Consultation.

Vaccine. 2014 Mar 20;32(14):1630-7. doi: 10.1016/j.vaccine.2014.01.053. Epub 2014 Jan 28. No abstract available.

PMID:
24480024
22.

Promising alternative settings for HPV vaccination of US adolescents.

Shah PD, Gilkey MB, Pepper JK, Gottlieb SL, Brewer NT.

Expert Rev Vaccines. 2014 Feb;13(2):235-46. doi: 10.1586/14760584.2013.871204. Epub 2014 Jan 3. Review.

23.

Sexually transmitted infections and women's sexual and reproductive health.

Gottlieb SL, Newman LM, Amin A, Temmerman M, Broutet N.

Int J Gynaecol Obstet. 2013 Dec;123(3):183-4. doi: 10.1016/j.ijgo.2013.09.013. Epub 2013 Sep 21.

PMID:
24144238
24.

Screening and treating Chlamydia trachomatis genital infection to prevent pelvic inflammatory disease: interpretation of findings from randomized controlled trials.

Gottlieb SL, Xu F, Brunham RC.

Sex Transm Dis. 2013 Feb;40(2):97-102. doi: 10.1097/OLQ.0b013e31827bd637. Review.

PMID:
23324973
25.

Human papillomavirus vaccine discussions: an opportunity for mothers to talk with their daughters about sexual health.

McRee AL, Gottlieb SL, Reiter PL, Dittus PJ, Tucker Halpern C, Brewer NT.

Sex Transm Dis. 2012 May;39(5):394-401. doi: 10.1097/OLQ.0b013e318248aaa0.

26.

Case-crossover analysis of condom use and herpes simplex virus type 2 acquisition.

Stanaway JD, Wald A, Martin ET, Gottlieb SL, Magaret AS.

Sex Transm Dis. 2012 May;39(5):388-93. doi: 10.1097/OLQ.0b013e318248aa8a.

27.

Acceptability of school requirements for human papillomavirus vaccine.

Smith JS, Brewer NT, Chang Y, Liddon N, Guerry S, Pettigrew E, Markowitz LE, Gottlieb SL.

Hum Vaccin. 2011 Sep;7(9):952-7.

28.

A prospective study of the psychosocial impact of a positive Chlamydia trachomatis laboratory test.

Gottlieb SL, Stoner BP, Zaidi AA, Buckel C, Tran M, Leichliter JS, Berman SM, Markowitz LE.

Sex Transm Dis. 2011 Nov;38(11):1004-11. doi: 10.1097/OLQ.0b013e31822b0bed.

PMID:
21992975
29.

Parent attitudes about school requirements for human papillomavirus vaccine in high-risk communities of Los Angeles, California.

Robitz R, Gottlieb SL, De Rosa CJ, Guerry SL, Liddon N, Zaidi A, Walker S, Smith JS, Brewer NT, Markowitz LE.

Cancer Epidemiol Biomarkers Prev. 2011 Jul;20(7):1421-9. doi: 10.1158/1055-9965.EPI-10-1236. Epub 2011 May 6.

30.

Mother-daughter communication about HPV vaccine.

McRee AL, Reiter PL, Gottlieb SL, Brewer NT.

J Adolesc Health. 2011 Mar;48(3):314-7. doi: 10.1016/j.jadohealth.2010.07.006.

31.

Uptake of 2009 H1N1 vaccine among adolescent females.

Reiter PL, McRee AL, Gottlieb SL, Markowitz LE, Brewer NT.

Hum Vaccin. 2011 Feb;7(2):191-6. Epub 2011 Feb 1.

32.

Mothers' support for voluntary provision of HPV vaccine in schools.

Kadis JA, McRee AL, Gottlieb SL, Lee MR, Reiter PL, Dittus PJ, Brewer NT.

Vaccine. 2011 Mar 21;29(14):2542-7. doi: 10.1016/j.vaccine.2011.01.067. Epub 2011 Feb 5.

33.

Human papillomavirus vaccine initiation among adolescent girls in high-risk communities.

Guerry SL, De Rosa CJ, Markowitz LE, Walker S, Liddon N, Kerndt PR, Gottlieb SL.

Vaccine. 2011 Mar 9;29(12):2235-41. doi: 10.1016/j.vaccine.2011.01.052. Epub 2011 Feb 1.

PMID:
21288799
34.

Correlates of receiving recommended adolescent vaccines among adolescent females in North Carolina.

Reiter PL, McRee AL, Gottlieb SL, Brewer NT.

Hum Vaccin. 2011 Jan 1;7(1):67-73. Epub 2011 Jan 1.

35.

The association between cervical abnormalities and attitudes toward cervical cancer prevention.

Salz T, Gottlieb SL, Smith JS, Brewer NT.

J Womens Health (Larchmt). 2010 Nov;19(11):2011-6. doi: 10.1089/jwh.2009.1790. Epub 2010 Sep 16.

PMID:
20846019
36.

Longitudinal predictors of human papillomavirus vaccine initiation among adolescent girls in a high-risk geographic area.

Brewer NT, Gottlieb SL, Reiter PL, McRee AL, Liddon N, Markowitz L, Smith JS.

Sex Transm Dis. 2011 Mar;38(3):197-204. doi: 10.1097/OLQ.0b013e3181f12dbf.

37.

Human papillomavirus vaccination practices: a survey of US physicians 18 months after licensure.

Daley MF, Crane LA, Markowitz LE, Black SR, Beaty BL, Barrow J, Babbel C, Gottlieb SL, Liddon N, Stokley S, Dickinson LM, Kempe A.

Pediatrics. 2010 Sep;126(3):425-33. doi: 10.1542/peds.2009-3500. Epub 2010 Aug 2.

PMID:
20679306
38.

HPV vaccine for adolescent males: acceptability to parents post-vaccine licensure.

Reiter PL, McRee AL, Gottlieb SL, Brewer NT.

Vaccine. 2010 Aug 31;28(38):6292-7. doi: 10.1016/j.vaccine.2010.06.114. Epub 2010 Jul 15.

39.

Summary: The natural history and immunobiology of Chlamydia trachomatis genital infection and implications for Chlamydia control.

Gottlieb SL, Martin DH, Xu F, Byrne GI, Brunham RC.

J Infect Dis. 2010 Jun 15;201 Suppl 2:S190-204.

PMID:
20524236
40.

Screening and treatment to prevent sequelae in women with Chlamydia trachomatis genital infection: how much do we know?

Gottlieb SL, Berman SM, Low N.

J Infect Dis. 2010 Jun 15;201 Suppl 2:S156-67. doi: 10.1086/652396. Review.

PMID:
20470051
41.

Risk of sequelae after Chlamydia trachomatis genital infection in women.

Haggerty CL, Gottlieb SL, Taylor BD, Low N, Xu F, Ness RB.

J Infect Dis. 2010 Jun 15;201 Suppl 2:S134-55. doi: 10.1086/652395. Review.

PMID:
20470050
42.

Introduction: The natural history and immunobiology of Chlamydia trachomatis genital infection and implications for chlamydia control.

Gottlieb SL, Brunham RC, Byrne GI, Martin DH, Xu F, Berman SM.

J Infect Dis. 2010 Jun 15;201 Suppl 2:S85-7. doi: 10.1086/652392. No abstract available.

PMID:
20470045
43.

Statewide HPV vaccine initiation among adolescent females in North Carolina.

Reiter PL, Cates JR, McRee AL, Gottlieb SL, Shafer A, Smith JS, Brewer NT.

Sex Transm Dis. 2010 Sep;37(9):549-56. doi: 10.1097/OLQ.0b013e3181d73bf8.

44.

The Carolina HPV immunization attitudes and beliefs scale (CHIAS): scale development and associations with intentions to vaccinate.

McRee AL, Brewer NT, Reiter PL, Gottlieb SL, Smith JS.

Sex Transm Dis. 2010 Apr;37(4):234-9. doi: 10.1097/OLQ.0b013e3181c37e15.

PMID:
19940807
45.

Prevalence of sexually transmitted infections among female adolescents aged 14 to 19 in the United States.

Forhan SE, Gottlieb SL, Sternberg MR, Xu F, Datta SD, McQuillan GM, Berman SM, Markowitz LE.

Pediatrics. 2009 Dec;124(6):1505-12. doi: 10.1542/peds.2009-0674. Epub 2009 Nov 23.

PMID:
19933728
46.

Availability of human papillomavirus vaccine at medical practices in an area with elevated rates of cervical cancer.

Gottlieb SL, Brewer NT, Smith JS, Keating KM, Markowitz LE.

J Adolesc Health. 2009 Nov;45(5):438-44. doi: 10.1016/j.jadohealth.2009.05.013. Epub 2009 Jul 22.

PMID:
19837349
47.

Human papillomavirus vaccine initiation in an area with elevated rates of cervical cancer.

Gottlieb SL, Brewer NT, Sternberg MR, Smith JS, Ziarnowski K, Liddon N, Markowitz LE.

J Adolesc Health. 2009 Nov;45(5):430-7. doi: 10.1016/j.jadohealth.2009.03.029. Epub 2009 Jun 24.

PMID:
19837348
48.

How much will it hurt? HPV vaccine side effects and influence on completion of the three-dose regimen.

Reiter PL, Brewer NT, Gottlieb SL, McRee AL, Smith JS.

Vaccine. 2009 Nov 16;27(49):6840-4. doi: 10.1016/j.vaccine.2009.09.016. Epub 2009 Sep 16.

49.

A pooled analysis of the effect of condoms in preventing HSV-2 acquisition.

Martin ET, Krantz E, Gottlieb SL, Magaret AS, Langenberg A, Stanberry L, Kamb M, Wald A.

Arch Intern Med. 2009 Jul 13;169(13):1233-40. doi: 10.1001/archinternmed.2009.177. Erratum in: Arch Intern Med. 2010 Jun 14;170(11):929.

50.

Parents' health beliefs and HPV vaccination of their adolescent daughters.

Reiter PL, Brewer NT, Gottlieb SL, McRee AL, Smith JS.

Soc Sci Med. 2009 Aug;69(3):475-80. doi: 10.1016/j.socscimed.2009.05.024. Epub 2009 Jun 18.

PMID:
19540642

Supplemental Content

Loading ...
Support Center